HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, Y. Articles by Deng, J. Search for Related Content PubMed PubMed Citation Articles by Liu, Y. Articles by Deng, J. Related Collections Coronary disease Myocardial infarction Myocardial protection

Eur J Cardiothorac Surg 2006;30:103-107
© 2006 Elsevier Science NL

Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging

^a Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, 15 Changlexi Road, Xi’an 710032, China
^b Department of Radiology, Xijing Hospital, Fourth Military Medical University, 15 Changlexi Road, Xi’an 710032, China

Received 8 November 2005; received in revised form 7 March 2006; accepted 10 March 2006.

^_* Corresponding author. Tel.: +86 29 84773592; fax: +86 29 84773592. (Email: Sunlijun20052005{at}126.com).

Objective: Therapeutic angiogenesis with angiogenic growth factors has described as one of the promising methods for collateral formation in the treatment of ischemic heart diseases. The purpose of this study is to assess the value of intramyocardial injection of slow-released basic fibroblast growth factor microspheres on angiogenesis and cardiac function in the early period of acute infarcted myocardium with dobutamine cardiovascular magnetic resonance tagging. Methods: Acute myocardial infarction was made by ligation of the left anterior descending coronary artery distal to its first diagonal branch. Immediately after coronary artery occlusion, 1 ml of saline containing 100 µg of basic fibroblast growth factor microspheres was injected into peri-infarct myocardial area in the basic fibroblast growth factor group, whereas only gelatin hydrogel microspheres with 1 ml of saline was given in control dogs. Cardiac function was evaluated by cine magnetic resonance imaging. Dobutamine cardiovascular magnetic resonance was performed at rest and during low doses of dobutamine to assess regional wall motion. Immunohistochemical study with von Willebrand factor was performed to observe angiogenesis. Results: Left ventricular ejection fraction improved markedly 10 and 17 days after treatment in the basic fibroblast growth factor group. The basic fibroblast growth factor group had more viable myocardium. Microvessel density was higher in the basic fibroblast growth factor group than in the control group except the first day after treatment. Conclusions: Intramyocardial administration of basic fibroblast growth factor microspheres can promote the growth of microvessels and improve left ventricular function and myocardial viability in the early period of acute myocardial infarction.

Key Words: Angiogenesis • Myocardial infarction • Basic fibroblast growth factor • MR tagging

This article has been cited by other articles:

				C. Heilmann and F. Beyersdorf Editorial comment Growth factor therapy grows, despite limited insight. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 107 - 108. [Full Text] [PDF]